CF
ABBV icon

Copperwynd Financial’s AbbVie ABBV Stock Holding History

Copperwynd Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$430K Buy
2,319
+22
+1% +$4.09K 0.11% 114
2025
Q1 		$481K Sell
2,297
-4,864
-68% -$946K 0.13% 111
2024
Q4 		$1.27M Buy
+7,161
New +$1.32M 0.35% 50
2024
Q3 		– Sell
-1,562
Closed -$289K – 142
2024
Q2 		$289K Buy
1,562
+356
+30% +$59K 0.09% 116
2024
Q1 		$220K Sell
1,206
-535
-31% -$92.2K 0.08% 133
2023
Q4 		$270K Buy
1,741
+53
+3% +$7.73K 0.11% 118
2023
Q3 		$252K Buy
1,688
+3
+0.2% +$440 0.12% 111
2023
Q2 		$227K Sell
1,685
-9,697
-85% -$1.42M 0.11% 122
2023
Q1 		$1.81M Buy
11,382
+1,370
+14% +$209K 0.93% 28
2022
Q4 		$1.62M Buy
10,012
+138
+1% +$21.2K 0.91% 24
2022
Q3 		$1.32M Sell
9,874
-138
-1% -$19.8K 0.76% 27
2022
Q2 		$1.53M Sell
10,012
-14,256
-59% -$2.18M 0.9% 27
2022
Q1 		$3.93M Buy
+24,268
New +$3.53M 1.63% 13

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Copperwynd Financial's ABBV Position: Q2 2025 in Review

Copperwynd Financial increased its AbbVie (ABBV) stake by 0.96% in Q2 2025, buying an estimated $4.09K and bringing the position to 2,319 shares worth $430K. The position accounts for 0.11% of the portfolio, ranked #114.

Copperwynd Financial first reported a position in ABBV in Q1 2022 and has held it in 13 quarters since. The position peaked at $3.93M in Q1 2022. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Copperwynd Financial held 2,319 shares of AbbVie worth $430K as of Q2 2025.
  • Copperwynd Financial bought 22 AbbVie shares in Q2 2025, an estimated $4.09K.
  • AbbVie made up 0.11% of Copperwynd Financial's portfolio in Q2 2025, its #114 holding.
  • Copperwynd Financial first reported a position in AbbVie in Q1 2022 and has held it in 13 quarters since.
  • Copperwynd Financial's AbbVie position peaked at $3.93M in Q1 2022.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Copperwynd Financial's 13F filing for Q2 2025, filed 24 Jul 2025.